Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JN.2.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.40NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.40NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GK.1.6.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GK.1.6.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-16939.3Singapore
GK.1.6.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GY.8NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GY.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GY.8NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XCWNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XCWNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XCWNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GA.2.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GA.2.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GA.2.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GK.3.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GK.3.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GK.3.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.2.3.21NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.2.3.21NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.2.3.21NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FL.36NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FL.36NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.36NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.5.108NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.5.108NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.108NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JS.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JS.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JS.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.5.104NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.5.104NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.104NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HH.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
HH.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HH.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FL.1.6NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FL.1.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.1.6NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GA.4.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GA.4.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GA.4.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GW.5.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GW.5.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GW.5.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JE.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JE.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JE.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
EG.5.2.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
EG.5.2.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used